Although innovative biotechnologies are developed continuously, the method of nucleic acid extraction stayed unchanged for several decades. The classical bind-wash-elute approach seemed sufficient, but the COVID-19 pandemic uncovered the need for a new technique to be able to process multiple samples fast and in parallel. BioEcho developed a completely new technology, which simplifies and speeds up the process of RNA extraction dramatically.
PCR-test reveals risk of genotoxity of genome editing
Latest NewsGerman researchers have presented a new method to assess on-target and off-target effects of CRISPR-Cas nucleases or TALENs.
EMA starts rolling review for Sputnik V vaccine
Latest NewsEMA’s human medicines committee has started a rolling review of Sputnik V, a COVID-19 vaccine developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology.
Novel RNA extraction method speeds up COVID-19 PCR tests
Sponsored PublicationsAlthough innovative biotechnologies are developed continuously, the method of nucleic acid extraction stayed unchanged for several decades. The classical bind-wash-elute approach seemed sufficient, but the COVID-19 pandemic uncovered the need for a new technique to be able to process multiple samples fast and in parallel. BioEcho developed a completely new technology, which simplifies and speeds up the process of RNA extraction dramatically.
Origenis founds biotech company Neuron23
Sponsored PublicationsTogether with star investor Kleiner Perkins, Origenis GmbH, a privately held German biopharmaceutical company, successfully establishes its new business model for the clinical development of its neuroprotective drug pipeline. The formation and financing of Neuron23 Inc. was announced in South San Francisco.
CAC builds biofuel plant for OMV
Latest NewsChemieanlagenbau Chemnitz (CAC) is realizing one of the first large-scale plants in Europe to use innovative co-processing to produce carbon-neutral fuels.
French biotech investors launch spin-out alliance
Latest NewsKurma Parnters and Francee investment bank have launched a €50m project named Argobio that is aimed at identifiying the most genious biotech ideas and spin out companies.
Oxular Ltd raises US$37m
Latest NewsBritish Oxular Ltd has raised $37m in a financing round led by Forbion Parners and co-financed by IP Group, NeoMed, and V-Bio Ventures to push its pipeline.
EU life science PPPs face less budget in Horizon Europe
Latest NewsThe European Commission is set to fund ten "European Partnerships" partnered with different industries with €10bn.
MosaMeat BV closes US$85m Series B financing
Latest NewsCultured meat producer MosaMeat BV has announced the third and final closing of its Series B round raising US$85m.
Knowledge Gain Through High Parallel Bioprocess Setups
ProductsDASbox® Mini Bioreactor System: In the Quality by Design (QbD) and Process Analytical Technology (PAT) era, the generation and validation of a large amount of data have become standard. Parallel bioreactor control systems offer the possibility to test and optimize different process parameters at the same time, thus saving time and resources.